Insomnia affects 67-88% of chronic pain patients. SPIN II is a randomized controlled clinical trial that will compare the effects of two cognitive behavioral sleep treatments in women with fibromyalgia and insomnia. This trial will yield important information about the roles of sleep, arousal, and brain structure and function in the development and maintenance of chronic pain in women with fibromyalgia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Self-Reported Bedtime, Wake time, Sleep Onset Latency, Wake After Sleep Onset, Sleep Quality on the Daily Diaries
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in Insomnia Severity Index (ISI)
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in Peripheral Arousal
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in Perceived Stress Scale
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in Dysfunctional Beliefs and Attitudes about Sleep (DBAS)
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in Pain Catastrophizing Scale
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in self-reported ratings of Pain Sensitivity and Pain Unpleasantness on Daily Diaries
Timeframe: baseline to follow-up (approximately 60 weeks)
Neural Imaging: Structural/Functional MRI/Diffusion Weighted Imaging
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in Bedtime, Wake time, Sleep Onset Latency, and Wake After Sleep Onset measured by Actigraphy
Timeframe: baseline to follow-up (approximately 60 weeks)
Change in Thermal Pain Response
Timeframe: baseline to follow-up (approximately 60 weeks)